Physical interaction of the bHLH LYL1 protein and NF-κB1 p105

被引:32
作者
Ferrier, R
Nougarede, R
Doucet, S
Kahn-Perles, B
Imbert, J
Mathieu-Mahul, D
机构
[1] Inst Genet Mol, UMR 5535, F-34293 Montpellier, France
[2] Inst J Paoli I Calmettes, INSERM, U119, F-13009 Marseille, France
关键词
bHLH; LYL1; NF-kappa b;
D O I
10.1038/sj.onc.1202374
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The LYL1 gene was first identified upon the molecular characterization of the t(7;9)(q35;p13) translocation associated with some human T-cell acute leukemias (T-ALLs), In adult tissues, LYL1 expression is restricted to hematopoietic cells with the notable exclusion of the T cell lineage. LYL1 encodes a basic helix-loop-helix (bHLH) protein highly related to TAL-1, whose activation is also associated with a high proportion of human T-ALLs. A yeast two-hybrid system was used to identify proteins that specifically interact with LYL1 and might mediate its activities. We found that p105, the precursor of NF-kappa B1 p50, was the major LYL1-interacting protein in this system. The association between LYL1 and p105 was confirmed both in vitro and in vivo in mammalian cells. Biochemical studies indicated that the interaction was mediated by the bHLH motif of LYL1 and the ankyrin-like motifs of p105. Ectopic expression of LYL1 in a human T cell line caused a significant decrease in NF-kappa B-dependent transcription, associated with a reduced level of NF-kappa B1 proteins.
引用
收藏
页码:995 / 1005
页数:11
相关论文
共 62 条
[1]   HIGH-LEVELS OF C-REL EXPRESSION ARE ASSOCIATED WITH PROGRAMMED CELL-DEATH IN THE DEVELOPING AVIAN EMBRYO AND IN BONE-MARROW CELLS IN-VITRO [J].
ABBADIE, C ;
KABRUN, N ;
BOUALI, F ;
SMARDOVA, J ;
STEHELIN, D ;
VANDENBUNDER, B ;
ENRIETTO, PJ .
CELL, 1993, 75 (05) :899-912
[2]   THE SCL GENE-PRODUCT - A POSITIVE REGULATOR OF ERYTHROID-DIFFERENTIATION [J].
APLAN, PD ;
NAKAHARA, K ;
ORKIN, SH ;
KIRSCH, IR .
EMBO JOURNAL, 1992, 11 (11) :4073-4081
[3]  
BAER R, 1993, SEMIN CANCER BIOL, V4, P341
[4]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[5]  
Baichwal VR, 1997, CURR BIOL, V7, P94
[6]   E2A PROTEINS ARE REQUIRED FOR PROPER B-CELL DEVELOPMENT AND INITIATION OF IMMUNOGLOBULIN GENE REARRANGEMENTS [J].
BAIN, G ;
MAANDAG, ECR ;
IZON, DJ ;
AMSEN, D ;
KRUISBEEK, AM ;
WEINTRAUB, BC ;
KROP, I ;
SCHLISSEL, MS ;
FEENEY, AJ ;
VANROON, M ;
VANDERVALK, M ;
TERIELE, HPJ ;
BERNS, A ;
MURRE, C .
CELL, 1994, 79 (05) :885-892
[7]   DOES ACTIVATION OF THE TAL1 GENE OCCUR IN A MAJORITY OF PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY [J].
BASH, RO ;
HALL, S ;
TIMMONS, CF ;
CRIST, WM ;
AMYLON, M ;
SMITH, RG ;
BAER, R .
BLOOD, 1995, 86 (02) :666-676
[8]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[9]   THE GENE SCL IS EXPRESSED DURING EARLY HEMATOPOIESIS AND ENCODES A DIFFERENTIATION-RELATED DNA-BINDING MOTIF [J].
BEGLEY, CG ;
APLAN, PD ;
DENNING, SM ;
HAYNES, BF ;
WALDMANN, TA ;
KIRSCH, IR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :10128-10132
[10]   2 DISTINCT MECHANISMS FOR THE SCL GENE ACTIVATION IN THE T(I-14) TRANSLOCATION OF T-CELL LEUKEMIAS [J].
BERNARD, O ;
GUGLIELMI, P ;
JONVEAUX, P ;
CHERIF, D ;
GISSELBRECHT, S ;
MAUCHAUFFE, M ;
BERGER, R ;
LARSEN, CJ ;
MATHIEUMAHUL, D .
GENES CHROMOSOMES & CANCER, 1990, 1 (03) :194-208